YS   $1.02  9.68% Market Closed

YS Biopharma Co Ltd
Total Cash 222.61M
totalCashPerShare 2.392
EBITDA -297.52M
Total Debt 558.09M
quickRatio 0.709
currentRatio 0.936
Total Revenue 544.09M
debtToEquity 117.614
Revenue/Share 4.67
ROA -0.10137
ROE -0.77799004
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth -0.092
grossMargins 0.80240995
ebitdaMargins -0.54682
operatingMargins -0.49502
profitMargins -0.66765
enterpriseValue 429.47M
forwardPE -4.08
floatShares 17.10M
sharesOutstanding 188.33M
sharesShort 38.89K
sharesShortPriorMonth 95.94K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.81%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.31%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 5.099
Price To Book help_outline 0.20
earningsQuarterlyGrowth
netIncomeToCommon -333.56M
trailingEps -0.56%
forwardEps -0.25%
enterpriseToEbitda -1.44
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.08 1Q 2024
institutionsCount 9
lastUpdated July 24, 2024, 3:20 p.m.